The feasibility of a hydrogen-based economy relies very much on the availability of catalysts for the hydrogen evolution reaction (HER) that are not based on Pt or other noble elements. Significant breakthroughs have been achieved with certain first row transition metal complexes in terms of low overpotentials and large turnover rates, but the majority of reported work utilized purified and deoxygenated solvents (most commonly mixtures of organic solvents/acids). Realizing that the design of earth abundant metal catalysts that operate under truly ambient conditions remains an unresolved challenge, we have now developed an electronically tuned Co(III) corrole that can catalyze the HER from aqueous sulfuric acid at as low as -0.3 V vs NHE, with a turnover frequency of 600 s(-1) and ≫10(7) catalytic turnovers. Under aerobic conditions, using H2O from naturally available sources without any pretreatment, the same complex catalyzes the reduction of H(+) with a Faradaic Yield (FY) of 52%. Density functional theory (DFT) calculations indicate that the electron density on a putative hydride species is delocalized off from the H atom into the macrocycle. This makes the protonation of a [Co(III)-H](-) species the rate determining step (rds) for the HER consistent with the experimental data.
Facile and selective 4e/4H electrochemical reduction of O to HO in aqueous medium has been a sought-after goal for several decades. Elegant but synthetically demanding cytochrome c oxidase mimics have demonstrated selective 4e/4H electrochemical O reduction to HO is possible with rate constants as fast as 10 M s under heterogeneous conditions in aqueous media. Over the past few years, in situ mechanistic investigations on iron porphyrin complexes adsorbed on electrodes have revealed that the rate and selectivity of this multielectron and multiproton process is governed by the reactivity of a ferric hydroperoxide intermediate. The barrier of O-O bond cleavage determines the overall rate of O reduction and the site of protonation determines the selectivity. In this report, a series of mononuclear iron porphyrin complexes are rationally designed to achieve efficient O-O bond activation and site-selective proton transfer to effect facile and selective electrochemical reduction of O to water. Indeed, these crystallographically characterized complexes accomplish facile and selective reduction of O with rate constants >10 M s while retaining >95% selectivity when adsorbed on electrode surfaces (EPG) in water. These oxygen reduction reaction rate constants are 2 orders of magnitude faster than all known heme/Cu complexes and these complexes retain >90% selectivity even under rate determining electron transfer conditions that generally can only be achieved by installing additional redox active groups in the catalyst.
The reduction of CO2 by an iron porphyrin complex with a hydrogen bonding distal pocket involves at least two intermediates. The resonance Raman data of intermediate I, which could only be stabilized at -95 °C, indicates that it is a Fe(II)-CO2(2-) adduct and is followed by an another intermediate II at -80 °C where the bound CO2 in intermediate I is protonated to form a Fe(II)-COOH species. While the initial protonation can be achieved using weak proton sources like MeOH and PhOH, the facile heterolytic cleavage of the C-OH bond in intermediate II requires strong acids.
A surprising effect of halide substituents on reduction potentials and catalytic activity of halogenated cobalt corroles has been deduced by experimental and computational methods; the proton-activating cobalt(I) and the cobalt(II) corrole that is formed in the step during which hydrogen is formed are characterized by NMR spectroscopy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.